A. Amkraut, G. Solomon, M. Allansmith, B. Mcclellan, and M. Rappaport, Immunoglobulins and Improvement in Acute Schizophrenic Reactions, Archives of General Psychiatry, vol.28, issue.5, pp.673-680, 1973.
DOI : 10.1001/archpsyc.1973.01750350053010

. American-psychiatric-association, Diagnostic and statistical manual of mental disorderscity, state: publisher. Manual of Mental Disorders, 1994.

C. B?l?i??, C. Iscrulescu, and A. Sârbulescu, Serum immunoglobulin levels in schizoaffective disorders (manic and depressive), Rom J Neurol Psychiatry, vol.30, issue.1, pp.63-71, 1992.

S. Buka, T. Cannon, E. Torrey, and R. Yolken, Maternal Exposure to Herpes Simplex Virus and Risk of Psychosis Among Adult Offspring, Biological Psychiatry, vol.63, issue.8, pp.809-824, 2008.
DOI : 10.1016/j.biopsych.2007.09.022

A. Brown, Exposure to prenatal infection and risk of schizophrenia. Front Psychiatry, p.63, 2011.

W. Chong-thim, T. Wing-foo, and S. Nilmani, Serum immunoglobulin levels in Chinese male schizophrenics, Schizophrenia Research, vol.10, issue.1, pp.61-67, 1993.
DOI : 10.1016/0920-9964(93)90077-V

F. Dickerson, J. Boronow, C. Stallings, A. Origoni, I. Ruslanova et al., Association of Serum Antibodies to Herpes Simplex Virus 1 With Cognitive Deficits in Individuals With Schizophrenia, Archives of General Psychiatry, vol.60, issue.5, pp.466-72, 2003.
DOI : 10.1001/archpsyc.60.5.466

F. Dickerson, J. Boronow, C. Stallings, A. Origoni, S. Cole et al., Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder, Biological Psychiatry, vol.55, issue.6, pp.588-93, 2004.
DOI : 10.1016/j.biopsych.2003.10.008

F. Dickerson, J. Boronow, C. Stallings, A. Origoni, and R. Yolken, Toxoplasma gondii in Individuals With Schizophrenia: Association With Clinical and Demographic Factors and With Mortality, Schizophrenia Bulletin, vol.33, issue.3, pp.737-777, 2007.
DOI : 10.1093/schbul/sbm005

J. Gowdy, Immunoglobulin levels in psychotic patients, Psychosomatics, vol.21, issue.9, pp.751-757, 1980.
DOI : 10.1016/S0033-3182(80)73619-8

A. Fontana, U. Storck, J. Angst, R. Dubs, A. Abegg et al., An Immunological Basis of Schizophrenia and Affective Disorders?, Neuropsychobiology, vol.6, issue.5, pp.284-293, 1980.
DOI : 10.1159/000117771

N. Hamdani, C. Daban-huard, and M. Lajnef, Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample, Journal of Affective Disorders, vol.148, issue.2-3, pp.2-3444, 2013.
DOI : 10.1016/j.jad.2012.11.034

T. Heatherton, L. Kozlowski, R. Frecker, and K. Fagerström, The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire, Addiction, vol.36, issue.9, pp.1119-1146, 1991.
DOI : 10.1016/0306-4603(90)90009-M

S. Kay, A. Fiszbein, and L. Opler, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophrenia Bulletin, vol.13, issue.2, pp.261-76, 1987.
DOI : 10.1093/schbul/13.2.261

S. Legros, J. Mendlewicz, and J. Wybran, Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders, European Archives of Psychiatry and Neurological Sciences, vol.128, issue.1, pp.9-11, 1985.
DOI : 10.1007/BF00380962

L. Lo, J. Shiea, and T. Huang, Rapid detection of alteration of serum IgG in patients with schizophrenia after risperidone treatment by matrix-assisted laser desorption ionization/time-of-flight mass spectrometry, Rapid Communications in Mass Spectrometry, vol.89, issue.Suppl. 1, pp.2645-2654, 2016.
DOI : 10.1093/schbul/sbt105

B. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick, Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects, Biological Psychiatry, vol.70, issue.7, pp.663-71, 2011.
DOI : 10.1016/j.biopsych.2011.04.013

S. Montgomery and M. Asberg, A new depression scale designed to be sensitive to change, The British Journal of Psychiatry, vol.134, issue.4, pp.382-391, 1979.
DOI : 10.1192/bjp.134.4.382

P. Mortensen, C. Pedersen, D. Hougaard, B. Nørgaard-petersen, O. Mors et al., A Danish National Birth Cohort study of maternal HSV-2 antibodies as a risk factor for schizophrenia in their offspring, Schizophrenia Research, vol.122, issue.1-3, pp.1-3257, 2010.
DOI : 10.1016/j.schres.2010.06.010

N. Muller and M. Schwarz, Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission, Neurotoxicity Research, vol.39, issue.9, pp.131-179, 2006.
DOI : 10.1093/schbul/17.4.669

N. Müller, E. Weidinger, B. Leitner, and M. Schwarz, The role of inflammation in schizophrenia, Frontiers in Neuroscience, vol.86, issue.9, p.372, 2015.
DOI : 10.1037/0021-843X.86.2.103

A. Muneer, Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers, Psychiatry Investigation, vol.33, issue.1, pp.18-33, 2016.
DOI : 10.1073/pnas.1209293109

D. Niebuhr, A. Millikan, D. Cowan, R. Yolken, Y. Li et al., Selected Infectious Agents and Risk of Schizophrenia Among U.S. Military Personnel, American Journal of Psychiatry, vol.165, issue.1
DOI : 10.1176/appi.ajp.2007.06081254

, Am J Psychiatry, vol.165, issue.1, pp.99-106, 2008.

N. , Genetics initiative: family interview for genetic studies (FIGS) National Institute of Mental Health: Rockville, 1992.

J. Nurnberger, M. Blehar, and C. Kaufmann, Diagnostic Interview for Genetic Studies (DIGS) Archives General Psychiatry, pp.849-59, 1994.

J. Nurnberger, . Jr, M. Blehar, C. Kaufmann, C. York-cooler et al., Diagnostic interview for genetic studies. Rationale, unique features, and training, NIMH Genetics Initiative. Arch General Psychiatr, vol.5, pp.849-64, 1994.

E. Pulkkinen, Immunoglobulins, psychopathology and prognosis in schizophrenia, Acta Psychiatrica Scandinavica, vol.35, issue.3, pp.173-82, 1977.
DOI : 10.1001/archpsyc.1962.01720020038006

J. Rosenblat and R. Mcintyre, Bipolar Disorder and Inflammation, Psychiatric Clinics of North America, vol.39, issue.1, pp.125-162, 2016.
DOI : 10.1016/j.psc.2015.09.006

A. Sane, M. Chawla, S. Chokshi, V. Mathur, D. Barad et al., Serum immunoglobulin status of psychiatric in-patients, Panminerva Med, vol.32, issue.2, pp.88-91, 1990.

S. Corp, Stats statistical software: release 13. College Station: StataCorp LP, 2013.

A. Sutterland, G. Fond, A. Kuin, M. Koeter, R. Lutter et al., in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis, Acta Psychiatrica Scandinavica, vol.38, issue.Pt 5, pp.161-179, 2015.
DOI : 10.1016/j.ijpara.2008.03.007

S. Tiwari, N. Lal, J. Trivedi, J. Sayeed, and L. Bahauguna, Immunoglobulin patterns in schizophrenic patients, Indian J Psychiatry, vol.26, issue.3, pp.223-231, 1984.

E. Toorey, M. Peterson, W. Brannon, W. Carpenter, R. Post et al., Immunoglobulins and viral antibodies in psychiatric patients, The British Journal of Psychiatry, vol.132, issue.4, pp.342-350, 1978.
DOI : 10.1192/bjp.132.4.342

B. Tudorache, C. B?l?i??, and D. Christodorescu, Serum immunoglobulin (a, G, M) levels in primary bipolar affective disorders, Rom J Neurol Psychiatry, vol.29, issue.12, pp.35-51, 1991.

A. Wadee, R. Kuschke, L. Wood, M. Berk, L. Ichim et al., Serological observations in patients suffering from acute manic episodes, Human Psychopharmacology: Clinical and Experimental, vol.29, issue.4, pp.175-184, 2002.
DOI : 10.1016/S0006-3223(98)00159-0

R. Yolken and E. Torrey, Viruses, schizophrenia, and bipolar disorder, Clin Microbiol Rev, vol.8, issue.1, pp.131-176, 1995.

R. Yolken, E. Torrey, and F. Dickerson, Evidence of increased exposure to Toxoplasma gondii in individuals with recent onset psychosis but not with established schizophrenia, PLOS Neglected Tropical Diseases, vol.17, issue.1, p.6040, 2017.
DOI : 10.1371/journal.pntd.0006040.t002

R. Young, J. Biggs, V. Ziegler, and D. Meyer, A rating scale for mania: reliability, validity and sensitivity, The British Journal of Psychiatry, vol.133, issue.5, pp.429-464, 1978.
DOI : 10.1192/bjp.133.5.429